Focused ultrasound for epilepsy in children
Part of Brain & nervous system clinical trials.
This trial tests a non-invasive procedure called magnetic resonance-guided focused ultrasound (MRgFUS) to treat epilepsy caused by brain lesions in children. This approach uses sound waves to target and destroy the lesion without surgery, which may reduce seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 4 and 17 years old
- Have seizures that don't improve with at least two different seizure medications
- Have a brain lesion (like a tumor or hamartoma) that can be seen on imaging and is causing the seizures
- Be able to fit into an MRI machine
- Be free of bleeding disorders or medications that increase bleeding risk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-invasive treatment using MRI-guided focused ultrasound to treat focal epilepsy that hasn't improved with medication. If you are not a candidate for open brain surgery, this ultrasound approach might offer a new option.
This trial tests whether focused ultrasound can help people whose seizures are not controlled by two or more medications. You would have a noninvasive procedure while awake, pressing a stop button if needed, and your hair will be partially shaved.
This study tests a non-invasive focused ultrasound treatment for people with epilepsy that doesn't respond to medications. The goal is to see if this gentle ultrasound can reduce seizures without surgery.
This study tests a new device called NaviFUS that uses focused sound waves to gently stimulate a small area of the brain. It is for people whose seizures start in one part of the brain and are not fully controlled by seizure medicines.
This pilot study tests whether low-intensity focused ultrasound can reduce seizures in adults whose temporal lobe epilepsy hasn’t improved with at least two anti-seizure medicines. You may be asked to track seizure timing and undergo brain imaging before and during the study.
This study tests if a new, non-invasive ultrasound treatment can safely reduce seizures in people whose seizures start in the temporal lobe and have not been controlled by at least two anti-epileptic drugs. The ultrasound is delivered through the scalp to gently stimulate the brain area where the seizures begin.
Hear when a new Drug Resistant Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.